Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brittany Thomas

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Genetic Testing|February 26, 2008
The value of MUTYH testing in patients with early onset microsatellite stable colorectal cancer referred for hereditary nonpolyposis colon cancer syndrome testingDouglas L Riegert-Johnson, Ruth A Johnson, Kari G Rabe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2008
TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cellsRossana Trotta, Jessica Dal Col, Jianhua Yu, et al.
The Journal of Experimental Medicine|September 19, 2007
The PP2A inhibitor SET regulates natural killer cell IFN-gamma productionRossana Trotta, David Ciarlariello, Jessica Dal Col, et al.
Orphanet Journal of Rare Diseases|May 24, 2024
Diagnostic yield of exome and genome sequencing after non-diagnostic multi-gene panels in patients with single-system diseasesMatheus V M B Wilke, Eric W Klee, Radhika Dhamija, et al.
Journal of Translational Medicine|June 23, 2023
Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)Filippo Pinto E Vairo, Jennifer L Kemppainen, Carolyn R Rohrer Vitek, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Genetic Testing|February 26, 2008
The value of MUTYH testing in patients with early onset microsatellite stable colorectal cancer referred for hereditary nonpolyposis colon cancer syndrome testingDouglas L Riegert-Johnson, Ruth A Johnson, Kari G Rabe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2008
TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cellsRossana Trotta, Jessica Dal Col, Jianhua Yu, et al.
The Journal of Experimental Medicine|September 19, 2007
The PP2A inhibitor SET regulates natural killer cell IFN-gamma productionRossana Trotta, David Ciarlariello, Jessica Dal Col, et al.
Orphanet Journal of Rare Diseases|May 24, 2024
Diagnostic yield of exome and genome sequencing after non-diagnostic multi-gene panels in patients with single-system diseasesMatheus V M B Wilke, Eric W Klee, Radhika Dhamija, et al.
Journal of Translational Medicine|June 23, 2023
Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)Filippo Pinto E Vairo, Jennifer L Kemppainen, Carolyn R Rohrer Vitek, et al.
Pageof 3